Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14+
SponsorNorthwestern University
About this trial
This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.
Eligibility criteria
Qualifiers
Ages 14-29
Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
Prescribed 6-mercaptopurine (6MP)
Disqualifiers
Cognitive impairments that would limit ability to complete measures, determined by the medical team
Absence of inclusion criteria above.
Nominated by the AYA as a primary caregiver involved in cancer care (can be a parent, relative, partner, friend)
English language proficiency
Trial design
Treatments tested in this trial
- ADAPTS (ADherence Assessments and Personalized Timely Support).
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov